(V1170) |
Residual aortic regurgitation impairs left ventricular structural and functional recovery after transcatheter aortic valve implantation: An analysis from a single center experience |
|
C. Merten, M. Abdel-Wahab, H. W. Beurich, D. Zachow, N. Wübken-Kleinfeld, M. El-Mawardy, G. Richardt (Bad Segeberg) |
(V1171) |
Emergent Cardiac Surgery During Transcatheter Aortic Valve Implantation (TAVI) - A Weighted Meta-Analysis of 9,251 Patients from 46 Studies |
|
H. Eggebrecht, A. Schmermund, P. Kahlert, R. Erbel, T. Voigtländer, R. Mehta (Frankfurt am Main, Essen; Durham, US) |
(V1172) |
Pre-Procedural Anemia is a Strong, Independent Predictor of Peri-Procedural and Mid-Term Mortaliy in Patients Undergoing Transcatheter Aortic Valve Implantation |
|
G. P. Diller, K. Gebauer, G. Kaleschke, G. Kerckhoff, A. Rukosujev, F. Ghezelbash, H. Reinecke, H. Baumgartner (Münster) |
(V1173) |
Vascular access site complications with a dedicated expandable sheath during transfemoral transcatheter aortic valve implantation (TF-TAVI) |
|
K. El Chilali, F. Al-Rashid, P. C. Patsalis, B. Plicht, R. Erbel, P. Kahlert, T. F. M. Konorza (Essen) |
(V1174) |
Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation and different valve types |
|
T. Schwietz, S. Behjati, F. Seeger, M. Doss, H. Sievert, A. M. Zeiher, S. Fichtlscherer, R. Lehmann (Frankfurt am Main) |
(V1175) |
Impact of aortic valve calcification severity and impaired left ventricular function on three-year results of patients undergoing transcatheter aortic valve replacement |
|
R. Koos, S. Reinartz, R. Herpertz, A. H. Mahnken, S. Lotfi, R. Autschbach, N. Marx, R. Hoffmann (Aachen) |